Drug profile · INN
ipodate sodium
BILIVIST
ipodate sodium (BILIVIST) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Drug details — ipodate sodium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
ipodate sodium (BILIVIST) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is ipodate sodium?
ipodate sodium (BILIVIST) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ipodate sodium?
BILIVIST is a marketed brand name for ipodate sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ipodate sodium?
ipodate sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.